News
11-24-2010, 06:10 AM
Breast cancer stem cells (CSCs), the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development. Disrupting the pathway, researchers were able to halt the expansion of breast CSCs, a finding that suggests a new drug therapy target...
More... (http://mnt.to/f/3N69)
More... (http://mnt.to/f/3N69)